Navigation Links
Stem-cell sentry sounds the alarm to maintain balance between cancer and aging, U-M researchers find
Date:10/15/2008

ANN ARBOR, Mich.---Like a sentry guarding the castle walls, a molecular messenger inside adult stem cells sounds the alarm when it senses hazards that could allow the invasion of an insidious enemy: Cancer.

The alarm bell halts the process of cell division in its tracks, preventing an error that could lead to runaway cell division and eventually, tumor formation.

"Our work suggests that to be able to prevent abnormal cell proliferation, which could lead to cancer, stem cells developed this self-checking system, what we're calling a checkpoint," said Yukiko Yamashita of the University of Michigan's Life Sciences Institute.

"And if it looks like the cell is going to divide in the wrong way, the checkpoint senses there's a problem and sends the signal: 'Don't divide! Don't divide!'" said Yamashita, a research assistant professor of life sciences and an assistant professor of cell and developmental biology at the U-M Medical School.

If everything looks OK, the checkpoint allows adult stem-cell division to proceed, providing new cells to replace damaged and worn-out tissues.

Yamashita and her colleagues have not yet identified the molecules that form the checkpoint mechanism. But they've seen it at work in adult stem cells of the fruit-fly testes, so-called germ-line stem cells.

"Aging is too few divisions and cancer is too many divisions, and people have long speculated that some process controls the balance between them," Yamashita said. "We may have found the mechanism that maintains the delicate balance between over-proliferation---which can lead to cancer---and aging."

The team's findings will be published Oct. 15 in the online version of the journal Nature.

If humans possess a similar checkpoint system and if researchers could someday harness it, they could fine-tune the rate of cellular division to control tumor development as well as tissue aging. But Yamashita stressed that no
'/>"/>

Contact: Jim Erickson
ericksn@umich.edu
734-647-1842
University of Michigan
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Non-Surgical Stem-Cell Procedure Relieves Degenerative Joint Disease
2. MIT: Stem-cell therapies for brain more complicated than thought
3. Reeve Foundation Recruits Distinguished Stem-Cell Neurobiologist - The Salk Institutes Samuel L. Pfaff, Ph.D. - to its International Research Consortium
4. Sentry Telecare Establishes Partnering Program to Market Telephone Check-in and Personal Emergency Response Service
5. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
6. Sentry Data Systems Announces Deficit Reduction Act Compliance Tool
7. MultiVu Video Feed: Parents of Kids With Infectious Diseases Sounds Alarm About the Dangers of Pertussis With "Silence the Sounds of Pertussis" Campaign
8. Brain Area Recognizes Familiar Sounds
9. Video: Could You Be At Risk? American Diabetes Association Sounds the Alert on March 25th - ADAs 20th Annual American Diabetes Alert(R) Day
10. Amateur Singers, Teachers Seldom Hear Sounds of Trouble
11. World No Tobacco Day Sounds Urgent Call for Nations to Fight Tobacco Use, Save Lives

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... in eventual development of screening test, resear...thDay News) -- New research points to the possibil...disease. , People with high blood pressure who ...on in the body were found to be twice as likely as...t failure, the study found. , The finding may l...
(Date:12/3/2009)...ONT, Calif., Dec. 3 The...eleased findings today from one of the largest stu...in women conducted by the Northern California Can...at women who never smoked cigarettes and who were ...ime--especially during adulthood--had a significan...
(Date:12/3/2009)... JOLLA, Calif., Dec. 3 ...iological Studies unanimously voted to elect thre...la. ,, Fred Dotzler is co-founder and Managin.... De Novo is investing $650 million from three fun... companies. Dotzler founded Medicus Venture Partne...
(Date:12/3/2009)...PASADENA, Calif., Dec. 3 For Calif... the risk of disability remains one of the most si...cial well being, but also their business,s viabili...ave taken their toll, owners of small businesses a...l safety net with enhanced disability coverage," s...
(Date:12/3/2009)...RASOTA, Fla., Dec. 3 If you have s...t ready for a stunning look at the other side of t...od will screen her feature documentary, "Superchar...ay, December 8th, 5 p.m. at Sever Hall, Harvard Ya...iving" College Tour. The film will be followed by ...
Breaking Medicine News(10 mins):Health News:Vitamin D May Be Tied to Heart Disease Via Genes 2Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 2Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 3Health News:New Disability Income Insurance Options Provide More Choice for California's Small Business Owners 4Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2
...inal Health, a global provider of products and ser...health care, today launched nine new products targ...perating rooms, including high-performance surgica...urgical scrubs market , Cardinal Health is enteri...
...Tools, Inc. is happy to announce the birth of Clin...ns developed exclusively to assist healthcare prov...nic Medical Record (EMR) designed to serve as a tr...e providers. , , ClinicTools(R) makes it easier ...
...e the Way People Think About End-of-Life , , Rece...er Ken Burns , , DETROIT, March 17 Hospice of Mi...pice organizations, has produced a documentary fil...- 5:30 pm. For television channels, see the tele...
... now just a phone call away for parents, pediatric...al professionals caring for any child in Ohio with...ess. , , The Comfort Line is a medical advice and... , Toll-free phone calls are accepted Monday throu...
...n syringes are the oldest delivery method availabl...e in Europe. Several factors have contributed to t...tance and popularity of insulin pens. , , (Logo:...n Insulin Delivery Devices Market , finds that the...
...st Listen is a newly launched service that provide...oking to talk, vent or just share what,s on their ...B) March 17, 2009 -- The stock market is in the ta...ut words not everyone may want to hear. Now, peopl...
Other Medicine News:Health News:Cardinal Health Launches New Products for the Operating Room 2Health News:Cardinal Health Launches New Products for the Operating Room 3Health News:Cardinal Health Launches New Products for the Operating Room 4Health News:Cardinal Health Launches New Products for the Operating Room 5Health News:Electronic Medical Record of the Future Is Here 2Health News:Hospice of Michigan Documentary to Air on Detroit Public Television Monday, March 23 and Sunday, March 29 2Health News:'Comfort' Now Available to Caregivers of Ohio's Seriously-Ill Children 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 2Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 3Health News:Insulin Pens and Growing Diabetic Community Increase Market for Insulin Delivery Devices in Europe, Says Frost & Sullivan 4Health News:Confidential Listening Service We Just Listen Launches, Providing Americans a Private Platform to Express Their Thoughts and Feelings 2
(Date:12/3/2009)... HOERSHOLM, Denmark and SAN DIEGO, California, Dec...ssfully Inhibits miR-122, a microRNA Important for...tly Reducing Hepatitis C,Virus in the Bloodstream ...itis C Virus , - SPC3649 Demonstrates Eff...Serious Adverse Events in the Treated Animals - Si...
(Date:12/3/2009)... Dec. 3 Cardium Therapeu...holly-owned subsidiary, Tissue Repair Company, sub... the U.S. Food and Drug Administration (FDA) seeki...duct candidate based on positive data from the Com... study. Today,s submission with the FDA covers Ex...
(Date:12/3/2009)...alif., Dec. 3 Jazz Pharm...that Kathryn E. Falberg has been appointed Senior ...alberg brings to Jazz Pharmaceuticals more than 20...e. As Jazz Pharmaceutical,s CFO, Ms. Falberg will...orate finance, financial planning, investor relati...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 1Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 2Weight Watchers 28R 29 Launches New Community on WeightWatchers com 55510 3Get Ready for Gruesome Cigarette Warnings 55508 1Get Ready for Gruesome Cigarette Warnings 55508 2Get Ready for Gruesome Cigarette Warnings 55508 3Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 1Mindray Medical to Participate in the SIG Third Annual Beijing Management Summit 55505 2
...Form Medical,Inc. (Nasdaq: BFRM ) today announced...nded comparative study of nasolabial fold treatmen...Radiesse(R) dermal filler,than reported after trea...results of this study were published in the Decemb...c Surgery, a peer-reviewed publication of the,Amer...
...ent in Motor Function at 24 Months, SAN DIEGO, De...llow-up data from a Phase 1 clinical trial of CERE...ase. CERE-120 uses gene therapy to,deliver the neu...eurodegeneration that occurs in the brains of Park...ssments at 18 and 24 months post,treatment, sugges...
Other Medicine Technology:Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 2Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 3Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 4Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 5Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery 6Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 2Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 3Ceregene Presents Long-term Follow-up From Phase 1 Trial of CERE-120 in Parkinson's Disease 4
Streck-Kleen Enzymatic Cleanser
Streck-Diluent III Plus Balanced Electrolyte Solution
Streck-CN free Lyse CD Lytic Reagent
...ted red blood cell (nRBC) control for evaluating t... 755 hematology analyzer in its enumeration of the...r LH 750/LH 755. nRBC-Chex for LH is a two-level c...nRBC-Chex for LH has a 75-day closed-vial stabilit...
Medicine Products: